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Software has become a prominent part of modern medical devices. In order to ensure 
safety of patients and users of medical devices, health authorities around the world have 
produced a number of regulations that control the development, manufacturing and sales 
of medical devices. Software which is part of a medical device must meet the same safety 
and quality requirements as the device itself. 
 
In Europe, Directive 2007/47/EC regulates the development and manufacturing of medical 
devices. International standardization organizations have produced harmonized standards 
such as IEC 62304 – medical device software – software life cycle processes to assist the 
manufacturers of medical devices in obtaining regulatory approvals. 
 
In recent years a new way to develop software known as Agile has emerged. Agile meth-
ods are based on an iterative and evolutionary software development life cycle. Although 
regulators do not mandate what software life cycle should be used, most of the regulations 
and standards assume a linear life cycle, such as waterfall. 
 
The Agile practices emerge from a common set of values and principles, such as quality of 
the software, productivity of the development teams and customer satisfaction. In this the-
sis we discuss how these values align with those of health authorities and regulators 
around the world. 
 
In this thesis we Introduce the Agile SW development practices in the context of a medical 
device company. We will analyze the European Medical Device Directives and internation-
al standards. We then propose a set of guidelines for the development of medical device 
software based on Agile practices while complying with the international standards. 
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1 Introduction 
A medical device is any instrument or apparatus used to diagnose, prevent or treat a 
medical condition. Medical devices vary in complexity, from a simple bandage to life 
sustaining equipment or sophisticated imaging devices such as MRI scans (Council 
Directive 2007/47/EC). 
In order to minimize the risks that the usage of medical devices may impose to human 
health, manufacturing and merchandizing of medical devices is regulated by the 
competent authorities (e.g., the Food and Drug Administration in the US or the 
European Commission in Europe). 
The number of medical devices functions performed by software is increasing greatly. It 
is not uncommon to find nowadays medical devices that are implemented purely by 
software. The safety regulations that apply to traditional medical devices apply also to 
the medical device software. Harmonized standards and guidelines exist to help 
manufactures of medical device software to comply with the requirements of these 
regulations. 
During the last years a new way to develop software has appear known as Agile (Agile 
Alliance, 2013). It started as a niche concept on small areas of the software industry 
but it has quickly gained traction and it is nowadays used in several software 
development contexts. For Agile to be widely used in the medical device software 
industry it has to be adapted to fit the needs of this unique context. 
In this thesis we will propose guidelines for the software development process for a 
new devices manufacturer willing to enter the medical device market. These guidelines 
will be based on Agile methodologies while complying with the medical device safety 
regulations. 
1.1 Case context 
Circular Devices Oy (hereafter “the case company”) is as recently established company 
that develops consumer electronics products with a focus on protection of the 
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environment, responsible sourcing of raw materials and production. They are 
developing PuzzlePhone, a modular, upgradeable and repairable smartphone. 
Alongside with PuzzlePhone, they are working on a vision based infant apnoea monitor 
intended to help on the prevention of Sudden Infant Death Syndrome (SIDS). 
SIDS is defined as the sudden death of an infant less than 1 year of age that cannot be 
explained after a thorough investigation is conducted, including a complete autopsy, 
examination of the death scene, and a review of the clinical history. SIDS is the leading 
cause of death in otherwise healthy infants 1 to 12 months old (National Centre for 
Chronic Disease Prevention and Health Promotion, 2015).  
The vision based infant apnoea monitor being developed uses machine vision 
algorithms to detect the baby’s respiratory movements and monitor his respiratory 
frequency. If there's no breath for a set number of seconds (a condition called apnoea) 
it produces an alarm to alert parents or other caregivers. 
1.2 Business problem, objective and intended outcome of this thesis 
Any device which primary function is, as defined by its manufacturer, to prevent, 
diagnose or treat a medical condition is considered as a medical device. Therefore, it 
must comply with the relevant medical device regulations before it can be sold 
(MEDDEV   2. 4/1 Rev. 9 2010). 
The infant apnoea monitor being developed by the case company is being advertised 
as a device that helps in the prevention of SIDS. Therefore, it must fulfil the 
requirements set by the competent authorities for medical devices. These apply both to 
the hardware and to the software components of the device. 
The objective of this thesis is to produce a set of guidelines that the case company 
should follow when developing its medical device software. We will study the European 
Medical Device Directives (MDD’s) that regulate the development of medical devices 
and analyse the international standards and industry guidelines concerning medical 
device software. 
The intended outcome of this thesis is a set of guidelines covering all phases of the 
software creation process (including development, maintenance, configuration and risk 
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management) based on Agile that fulfils the safety and performance requirements set 
for medical device software. We will focus on the European market although most of 
what is being proposed here would be easily adapted to comply with the requirements 
from other regions regulators, such as the FDA in the US. 
1.3 Research design 
As we discussed earlier in this chapter, this thesis address a real business problem 
faced by the case company: the infant monitor being developed will be sold and 
advertised as a device that helps in the prevention of SIDS. Any device which primary 
function is to treat or prevent a medical condition is considered a medical device and 
hence it must comply with the safety and quality requirements set by regulators. These 
requirements apply to all the components of the medical device, including its software. 
The objective of this thesis is to propose a set of guidelines for the software 
development process based on Agile methodologies while complying with the safety 
and quality requirements for medical devices. For the production of these guidelines, 
we will first study in depth the legal framework and standards that apply to medical 
device software. These guidelines will be shaped as well by the best practices 
identified during a literature review of published case studies from companies that 
apply Agile when developing medical device software as well as from insights obtained 
from the industry experts being interviewed. 
The figure below represents the different steps of the research design used in this 
thesis: 
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Figure 1.1 - Research design of this thesis 
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This study begins with the definition of the business problem of the case company as 
previously described. We will then introduce the Agile software development concepts 
and perform a literature review of some case studies in which Agile has been 
previously introduced in medical device software companies. We will study the relevant 
European Medical Device Directives, the corresponding international standards used to 
assess compliance as well as industry guidelines that assist medical device 
manufactures on the implementation of these standards. Some industry experts will be 
interviewed to understand how they apply Agile practices at their organizations, what 
Agile practices enhance safety and quality when developing medical device software 
and what hurdles they found when adopting Agile practices. After that, a software 
development process proposal will be presented. The purpose of this proposal is to 
serve as a guideline for the case company for the development of its own medical 
device software in a way that it benefits from the productivity and software quality 
improvements achieved when using Agile methods while demonstrating compliance 
with the medical device regulations. 
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2 Agile SW Development Practices in the Context of Medical Device 
Software Development 
2.1 Agile vs. plan driven development life cycles 
Software development teams are under pressure to develop and deliver software faster 
not only meeting their customer’s requirements but exceeding them. Traditional plan-
driven, document intensive, software life cycles such as Waterfall or V-Model, where 
planning of the software requirements is being done up front, followed by architectural 
design, module design, implementation, testing, system integration and validation, 
which each of these steps being done following a sequential order, make it very difficult 
and costly to accommodate to changes during the latest phases of the development 
process. 
 
Figure 2.1 - Waterfall life cycle model 
In a sequential development life cycle, each activity is performed in a certain, fixed 
order. The next one is not started before the previous one is completed (e.g., 
requirements definition precedes architectural design; hence the requirements need to 
be fully defined before the design of the architecture can start, and so on).  
Iterative software development appeared to offer a solution by aiding faster 
development of systems. In an iterative life cycle, these activities are performed several 
times during the development process. In an evolutionary life cycle, a system is 
developed in a number of consecutive builds. An evolutionary strategy is similar to an 
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incremental strategy in that after each iteration, an increment of the system is being 
delivered, but differs in acknowledging that the user needs are not fully understood and 
all requirements cannot be defined up front. In this strategy, user and system 
requirements are partially defined at the early stages of the development. Then they 
are refined in each successive build. Agile is a subset of these iterative techniques 
(Agile Alliance, 2013).  
The flow diagram below illustrates the evolutionary approach as described by AAMI in 
their TIR45:2012: 
 
Figure 2.2 - Evolutionary life cycle model 
The evolutionary approach puts a bigger emphasis on customer feedback, which is an 
essential component of Agile. In this model, there is a preliminary requirement analysis 
followed by an initial, high level design and architecture definition which is “just enough” 
to get started with the version build cycle. This cycle is being repeated until the 
customer is satisfied or we run out of time or money (whichever occurs first). 
Agile was developed in response to quality and efficiency concerns present in existing 
software development methodologies. Agile bring benefits to software development 
teams in the following areas (Association for the Advancement of Medical 
Instrumentation, 2012): 
 Continuous focus on safety, risk management and delivering customer value 
through backlog prioritization, planning practices and customer feedback 
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 Continuous assessment of quality through continuous integration and testing 
 Continuous improvement of the software development process through 
retrospectives and team accountability 
 Continuous focus on “getting to done” and satisfying quality management 
stakeholders through the regular completion of activities and deliveries 
It is apparent that any organization, including those developing software in a highly 
regulated and controlled environment such as a medical device context, can benefit 
from these improvements. Because Agile initially grew from the IT industry where 
human safety and risk management were not of primary importance, there are some 
concerns about Agile compatibility with the regulated world of medical device software 
development. Fortunately, as we shall discuss later in this chapter, the fundamental 
nature of Agile is to be adaptable to the context in which it is being utilized, 
encouraging its practices to be adapted to this particular context in ways that they are 
compatible with the needs of the safety-critical medical device software development 
world. 
Agile methodologies (Scrum, Extreme Programming, Kanban, etc.) are made of Agile 
practices, such as sprint planning, daily stand ups, product backlog, pair programing 
and so forth (Mc Hugh et al., 2012). 
Agile methodologies such as Scrum and XP are becoming increasingly popular in 
traditional software development projects. Some case studies exist where Agile 
practices have being used when developing software for safety critical applications 
(Drobka et al., 2004), (Grenning, 2001). These cases studies show a significant 
improvement in the productivity of the team and in the quality of the software being 
developed when compared to plan-driven software development projects. However, 
Agile methods present certain challenges for highly regulated industries, such as the 
production of documentation and verification of the traceability from end product to 
customer requirement. 
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2.2 Agile values, principles and practices 
Agile software development is a set of values, principles and practices that self-
organizing teams use to quickly and regularly deliver software that provide value to 
their customers. It follows an incremental and evolutionary life cycle. Agile puts a 
bigger emphasis on collaboration between the development team, the customer and 
other stakeholders. Agile recognizes the need to adapt its practices to the context in 
which software is being developed. 
Agile software development utilizes a completely different paradigm to that of traditional 
software development processes. This new way of developing software is rooted in a 
set of values, principles and practices that guide Agile teams when performing their 
work. 
Values are abstract, universal concepts that all members of the team believe provide 
value to the team as a whole: it is not how any member of the team behaves what 
matters, but how individuals behave as part of a team. It is important that the team 
adapts its behaviour to its values. Values don’t provide concrete advice on what to do 
in software development. Values held by the team shape its practices in ways that 
benefit the team needs. 
Practices are the common procedures and the routines that the team follows in a 
regular basis when developing software. Practices are the visible artefacts of the way 
the team works. Practices are evidence of values. Just as values bring purpose to 
practices, practices bring accountability to values. Practices are clearly stated. They 
are defined to address a real life software development problem (for example, lack of 
communication, poor quality of the code, lack of code reviews, etc.). Practices are 
highly situated and should be considered in the particular context of the team. 
Principles bridge the gap between values and practices. Principles are a set of domain-
specific guidelines for finding practices in harmony with the values of Agile. While the 
statement of the practices is intended to be clear and objective, understanding how to 
apply the practices in a given context might not be obvious. These principles give a 
better idea of what the practice is intended to accomplish (Beck 2004). 
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2.2.1 Manifesto for Agile Software Development 
The Agile values are captured by the Agile Manifesto (Beck et al. 2001) 
We are uncovering better ways of developing software by doing it and 
helping others do it. Through this work we have come to value: 
 
Individuals and interactions over processes and tools 
Working software over comprehensive documentation 
Customer collaboration over contract negotiation 
Responding to change over following a plan 
 
That is, while there is value in the items on the right, we value the items 
on the left more. 
The Agile Manifesto is a clear, powerful and provocative statement of the values that 
drive Agile software development. The values of this manifesto can seem to be 
contradictory to those of the regulated world of medical device software. However, 
when interpreted correctly, they enhance the value of quality management systems 
required by regulations and standards: The goals of Agile are to provide benefits in the 
quality of the product, improve the product’s effectiveness and increase the productivity 
and predictability of the development team. 
The last phrase of the Agile Manifesto “while there is value in the items on the right, we 
value the items on the left more” provides a vital qualification of the Agile values. Many 
of those that oppose to the use of Agile on safety critical software development inferred 
that the word “over” here means “instead of”, leading to the incorrect conclusion that 
Agile practices required no documentation, no processes and so on. Or that regulations 
required things that are not “Agile”. Thoughtful consideration of this phrase is essential 
to the proper application of Agile when developing medical device software in order to 
find the proper balance of what is valued. 
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Individuals and interactions over processes and tools 
This value recognizes that skilled people working well together will produce good 
software and that processes and tools are useful but insufficient. Effective processes 
and tools will help a good team perform even better. But no amount of processes and 
tools will help a poor team perform well. 
Software development is a creative process; hence developers and designers have to 
be allowed to think, to create and to solve problems. Good software can’t be produced 
by following processes and check-lists alone. 
A criticism to this value is that it might lead to a lack of discipline. That could be true if 
this value would be taken to the extreme. However, if applied with balance it can lead 
to an even better discipline. Formal processes and support tools bring discipline to a 
software development process when they codify behaviors that the team consider 
important. This kind of discipline is useful for bringing consistency to the way the team 
work together. However, this can lead to negative output if the team doesn’t feel 
responsible of the processes, leading to processes that are misunderstood or ignored. 
Working software over comprehensive documentation 
This value recognizes that working software is the ultimate deliverable, the best 
indicator of progress and the best way to assess whether the needs of the customer 
are being satisfied. Documentation is necessary and useful but it is of little value if it 
doesn’t come together with working software. Documentation, when clear and 
sufficient, helps the team in developing a good software product. It also helps external 
stakeholders evaluating the completeness and quality of the software that has been 
delivered. 
Agile can’t be used as an excuse to not producing the needed documentation. Agile 
values and specially the principle of “mutual benefit” has to be applied to ensure that 
valuable documentation that benefits both the team and external stakeholders is 
produced and that wasteful documentation is eliminated. 
Customer collaboration over contract negotiation 
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This value recognizes that collaboration with a customer who is engaged in the 
development process is more likely to deliver software that meets the customer’s 
needs. Contracts alone cannot guarantee that the team will produce software that 
fulfills the customer’s requirements. However, clear contracts are useful to establish a 
common understanding and to set reasonable expectations. Inflexible contracts can 
hinder innovation, which is essential when developing a new software product. 
In medical devices software development it can be challenging to determine who the 
customer is. Medical software can be used by multiple users and it is typically part of a 
wider system. Moreover, the software definition will evolve over time. It is important to 
establish a customer role in the development team and mechanism that support 
emergent product definition. 
Responding to change over following a plan 
This value recognizes that change is inevitable in new product development and should 
be embraced as a good and useful thing. Plans alone are not enough to ensure that a 
good product will be delivered. 
In Agile software development, planning occurs at different levels during the product 
development life cycle, from a coarse-grained plan to a detailed one as the features are 
being implemented. This sequential planning allows the team to incorporate feedback 
and make adjustments as software is being developed; minimizing waste in form of 
very detailed up-front plans in case radical and unexpected changes occur that impact 
greatly the software being developed. 
It is important to define planning mechanisms and to establish feedback mechanisms 
to demonstrate effective control of changes. 
2.2.2 Agile principles 
The principles behind the Agile manifesto are: 
 Our highest priority is to satisfy the customer through early and continuous 
delivery of valuable software. 
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 Welcome changing requirements, even late in development. Agile processes 
harness change for the customer's competitive advantage. 
 Deliver working software frequently, from a couple of weeks to a couple of 
months, with a preference to the shorter timescale. 
 Business people and developers must work together daily throughout the 
project. 
 Build projects around motivated individuals. Give them the environment and 
support they need, and trust them to get the job done. 
 The most efficient and effective method of conveying information to and within 
a development team is face-to-face conversation. 
 Working software is the primary measure of progress. 
 Agile processes promote sustainable development. The sponsors, developers, 
and users should be able to maintain a constant pace indefinitely. 
 Continuous attention to technical excellence and good design enhances agility. 
 Simplicity--the art of maximizing the amount of work not done--is essential. 
 The best architectures, requirements, and designs emerge from self-organizing 
teams. 
 At regular intervals, the team reflects on how to become more effective, then 
tunes and adjusts its behaviour accordingly. 
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In the next section we will discuss how these principles align with the special needs of 
medical device software development. 
2.2.3 Agile principles in the context of medical device software 
There are many publications that describe the principles of Agile software development 
in the context of traditional, non-regulated software development. Here we will 
introduce a list of principles that are relevant in the context of medical device software 
development, as described by the Association for the Advancement of Medical 
Instrumentation in their TIR45:2012 Guidance on the use of AGILE practices in the 
development of medical device software (Association for the Advancement of Medical 
Instrumentation, 2012): 
 Apply incremental and evolutionary lifecycle concepts 
 Define what DONE means 
 Deliver customer value, with the highest priority features first, through collabora-
tion between the team and the customer 
 Accept that customer needs and requirements are likely to change throughout 
the project and accommodate to this change in an effective and efficient way 
 Manage project risks through increased visibility and team accountability 
 Empower the teams to become self-organized and to manage the daily tasks 
 Seek for technical excellence in the software through high-quality designs and 
verification practices 
 Reflect and adapt the process at regular intervals to constantly improve quality 
and efficiency of the work 
 Satisfy business stakeholders, both internal and external 
2.2.4 Agile practices in the context of medical device software 
The fundamental nature of Agile is to be adaptable to the context in which it is being 
applied. The following summarizes the Agile practices relevant to the development of 
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medical device software gathered from various Agile methodologies (Scrum, XP, etc.) 
They have been grouped according to the software development phase that they apply: 
 Product definition: product vision/vision statement, product backlog, 
epic/stories/use cases/personas, backlog management, planning poker 
 Product implementation: emergent/evolutionary design, refactoring, 
architecture spikes, coding guidelines/standards, test driven development 
(TDD), continuous integration, daily builds/automated builds, frequent 
delivery/frequent releases, unit testing, story testing/executable requirements, 
and test automation 
 Project execution: time boxing/fixed increments length, release planning, 
increment planning, daily planning, definition of done, and velocity/burn 
down/burnup charts 
 Team organization: self-organizing teams, team roles, team size, scrum of 
scrums and sustainable pace 
 Team collaboration: stop-the-line/information radiators, co-location, pairing, 
reflections/retrospectives, and collective ownership 
2.3 Summary of the conceptual framework 
Agile software development is based on a set of values, principles and practices that 
self-organizing teams use to quickly and regularly deliver software that provide value to 
their customers, in an evolutionary and incremental manner. 
Values are abstract, universal concepts that all members of the team believe provide 
value to the team. It is important that the team adapts its behaviour to its values. 
Values held by the team shape its practices in ways that benefit the team needs. 
Practices are the common procedures and the routines that the team follows in a 
regular basis when developing software. Practices are evidence of values. Practices 
are clearly stated. They are defined to address a real life software development 
problem. Practices are situated and should be considered in the particular context of 
the team. 
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Principles bridge the gap between values and practices. Principles are a set of domain-
specific guidelines for finding practices in harmony with the values of Agile. These 
principles offer a better idea of what the practice is intended to accomplish. 
The table below summarizes the values, principles and practices that define the ways 
of working of an Agile software development team in the context of medical device 
software development: 
Table 2.1 - Agile values, principles and practices 
Values Principles Practices 
Individuals and 
interactions over 
processes and 
tools 
Incremental and 
evolutionary lifecycle 
Product definition: product vision/vision statement, 
product backlog, epic/stories/use cases/personas, 
backlog management, planning poker. 
Working software 
over comprehen-
sive documenta-
tion 
Definition of DONE Product implementation: emergent/evolutionary 
design, refactoring, architecture spikes, coding guide-
lines/standards, test driven development (TDD), con-
tinuous integration, daily builds/automated builds, fre-
quent delivery/frequent releases, unit testing, story 
testing/executable requirements, and test automation 
Customer collab-
oration over con-
tract negotiation 
Deliver customer val-
ue, with the highest 
priority features first, 
through customer col-
laboration 
Project execution: time boxing/fixed increments 
length, release planning, increment planning, daily 
planning, definition of done, and velocity/burn 
down/burnup charts 
Responding to 
change over fol-
lowing a plan 
Embrace change of 
customer needs 
throughout the project 
Team organization: self-organizing teams, team 
roles, team size, scrum of scrums and sustainable 
pace 
 
Manage project risks 
through increased vis-
ibility and team ac-
countability 
Team collaboration: stop-the-line/information radia-
tors, co-location, pairing, reflections/retrospectives, 
and collective ownership 
 
Empower the teams to 
become self-organized 
and to manage the daily 
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tasks 
 
Seek for technical ex-
cellence in the software 
through high-quality 
designs and verification 
practices 
 
 
Reflect and adapt the 
process at regular inter-
vals to constantly im-
prove quality and effi-
ciency of the work 
 
 
Satisfy business 
stakeholders, both 
internal and external 
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3 Analysis of the Medical Device Directives and Standards 
3.1 Definition of Medical Device 
A medical device is defined as an instrument, apparatus, implant, in vitro reagent, or 
similar or related article that is used to diagnose, prevent, or treat disease or other 
conditions, and does not achieve its purposes through chemical action within or on the 
body (which would make it a drug) (U.S. Food and Drug Administration, 2014). 
Medical devices can vary greatly in complexity ranging from a simple bandage or 
dressing to a pacemaker, cochlear implant or a life sustaining medical ventilator. 
In Europe, Directive 2007/47/EC defines a medical device as: “Any instrument, 
apparatus, appliance, software, material or other article, whether used alone or in 
combination, together with any accessories, including the software intended by its 
manufacturer to be used specifically for diagnostic and/or therapeutic purposes and 
necessary for its proper application, intended by the manufacturer to be used for 
human beings for the purpose of: 
 Diagnosis, prevention, monitoring, treatment, or alleviation of disease 
 Diagnosis, monitoring, treatment, alleviation of, or compensation for an injury or 
handicap 
 Investigation, replacement, or modification of the anatomy or of a physiological 
process 
 Control of conception 
This includes devices that do not achieve their principal intended action in or on the 
human body by pharmacological, immunological, or metabolic means—but may be 
assisted in their function by such means” (Council Directive 2007/47/EC). 
This definition includes explicitly the term “software”, whether used alone or in 
combination. This is an important remark, since now the definition includes not only the 
embedded software which is part of a medical device, but also standalone software 
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that runs on off-the-shelf computer hardware such as personal computers, 
smartphones, tablets and even smart watches. 
The manufacturing and commercialization of medical devices is a regulated activity. 
The manufacturer of medical devices must comply with the requirements set by the 
regulatory agencies of the geographical areas where it intend to market its devices (the 
FDA in U.S., European Commission in Europe, etc.). 
Medical devices must not endanger the safety or health of the patient or the caregivers. 
The manufacturer of a medical device must ensure: 
 Safety 
 Suitability for the intended use 
 Performance and reliability 
In the following section we will introduce the legal framework that regulates the 
manufacturing and commercialization of medical device in Europe, its safety 
classification and the certification process. 
3.2 EU MD Directives 
In Europe the following directives define the rules that regulate the safety and 
performance of medical devices: 
 Council Directive 90/385/EEC regarding active implantable medical devices 
 Council Directive 93/42/EEC concerning medical devices 
 Council Directive 98/79/EC regarding in vitro diagnostic medical devices 
These three main directives have been supplemented over time by several modifying 
and implementing directives, including the last technical revision brought about by 
Directive 2007/47 EC. 
20 
 
 
They aim at ensuring a high level of protection of human health and safety and the 
good functioning of the Single Market by eliminating technical barriers to trade and 
dispel the consequent uncertainty for economic operators. 
The government of each Member State must appoint a competent authority 
responsible for medical devices. The competent authority (CA) is a body with authority 
to act on behalf of the member state to ensure that member state government 
transposes requirements of Medical Device Directives into national law and applies 
them. The CA reports to the minister of health in the member state. The CA in one 
Member State has no jurisdiction in any other member state, but exchanges 
information and tries to reach common positions. 
The European Commission provides a set of guidelines to help medical device 
manufactures in the implementation of these directives (European Commission 2015) 
The guidelines aim at promoting a common approach by manufacturers and Notified 
Bodies involved in the conformity assessment procedures according to the relevant 
annexes of the directives, and by the Competent Authorities charged with safeguarding 
Public Health. 
3.2.1 Classification of medical devices 
The classification of medical devices in the European Union is outlined in Annex IX of 
the Council Directive 93/42/EEC. There are basically four safety classes, ranging from 
low risk to high risk. 
 Class I (including Is & Im) 
 Class IIa 
 Class IIb 
 Class III 
The purpose of establishing a classification scale is to ensure an adequate level of 
supervision and validation based on the potential risk that patients or caregivers could 
be exposed when using the device, since it wouldn’t be feasible or economically viable 
to impose the strictest controls to each and every medical device. 
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The authorization of medical devices is guaranteed by a Declaration of Conformity. 
This declaration is issued by the manufacturer itself, but for products in Class Is, Im, 
IIa, IIb or III, it must be verified by a Certificate of Conformity issued by a Notified Body. 
A Notified Body is a public or private organisation that has been accredited to validate 
the compliance of the device to the European directive. Medical devices that pertain to 
class I (on condition they do not require sterilization or do not measure a function) can 
be sold purely by self-certification. 
The European classification depends on rules based on the following: 
 The medical device's duration of body contact 
 Invasive character 
 Use of an energy source 
 Effect on the central circulation or nervous system 
 Diagnostic impact 
 Incorporation of a medicinal product 
The European Commission has published a guidance document to help medical 
devices manufacturers and notified bodies in the application of the classification rules 
defined by the Council directive 93/42/EEC. This document provides advice when 
using the classification rules and illustrates them with practical examples. 
When interpreting the classification rules manufactures should bear in mind the 
following: 
 It is the intended purpose that determines the class of the device and not its 
particular technical characteristics 
 It is the Intended use and not the accidental use of the device that determines 
its class 
 It is the Intended purpose assigned by the manufacturer to the device that 
determines it class and not the class assigned to other similar products 
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 A device that is part of a system may be classed as a device on its own right 
rather than classifying the system as a whole 
 Accessories of medical devices are classified in their own right separately from 
the device that they are used with 
 General purpose devices that are used in combination with medical devices are 
not considered medical devices 
Certified medical devices should have the CE mark on the packaging, insert leaflets 
and other marketing material or documentation. The packaging should also show 
harmonised pictograms and EN standardised logos to indicate essential features such 
as instructions for use, expiry date, manufacturer, sterile, don't reuse, etc. 
3.3 Medical Device Software 
As previously stated, the legislation that regulates the manufacturing and 
commercializing of medical devices in Europe apply as well to the software 
components of medical devices. In particular, Directive 2007/47/EC which amended 
the definition of the term “medical device” used in Directives 90/385/EEC and 
/93/42/EEC. Recital 6 of Directive 2007/47/EC, states that “it is necessary to clarify that 
software in its own right, when specifically intended by the manufacturer to be used for 
one or more of the medical purposes set out in the definition of a medical device, is a 
medical device. Standalone software for general purposes when used in a healthcare 
setting is not a medical device.” 
In the following section we will highlight the motivation behind medical device software 
regulations and the objectives that competent authorities seek to achieve with said 
regulations. 
3.3.1 Regulatory goals, values, principles and practices 
Regulatory agencies are responsible for protecting the health of patients, caregivers 
and others by assuring the safety, security and efficacy of medical devices. 
Regulatory goals are to provide benefits on the following areas: 
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 Quality: correctness of the product, reliability, free of defects 
 Safety: identification and mitigation of safety risks to patients and users 
 Effectiveness: delivering value to the patient and users, satisfying customers’ 
needs 
The regulatory values and principles can be derived from the regulations, standards 
and guidelines. The following are some principles that are relevant when developing 
medical device software: 
 Established and controlled design and development processes are 
essential when producing high quality software. The level of control and the 
amount of effort devoted to it should be decided based on the intended use and 
the level of safety associated with the software being developed 
 Software verification and validation must be conducted throughout the 
development of the software regardless the chosen life cycle model 
 Quality systems must be put in put in place to ensure that the software meets 
the customer requirements with the best level of correctness and free of 
defects. Quality rely on management control, professional work and 
professional training 
 Documentation is necessary to demonstrate compliance to regulations, to 
facilitate the maintenance, investigation of software problems and to evaluate 
software for those devices requiring regulatory approval 
 Planning is essential to ensure a high quality and an efficient implementation of 
the software product. Risk management activities should be conducted as part 
of the software development activities 
The software development practices that are encouraged by the regulatory perspective 
can be grouped in categories based on the problem that they attempt to solve: 
 Patient safety and risk management: identification of risk scenarios, risk 
mitigation, verification to assess the remaining risks in a software product 
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 Quality planning: management controls, planning of the software development 
environment, team development and training 
 Documentation: document controls, configuration management and change 
controls 
 Software definition: user requirements, design requirements and definition of 
system and software interfaces 
 Software design: architecture design, detailed design, implementation and 
design change management 
 Verification and validation: design reviews, peer reviews, unit, integration and 
system testing and user validation 
Regulations and standards do not usually specify how these activities must be 
performed. This allows manufacturers to design their own practices in a way that suits 
their needs best and aligns with their own ways of working and culture while 
maintaining conformity with regulatory principles. 
Once we have outlined the motivations and objectives behind the directives that 
regulate medical devices, we will next introduce the standards and technical reports 
that help manufacturers of medical device to comply with those regulations. 
3.4 Standards, technical reports and guidance documents 
As discussed in section 4.2, manufactures of medical devices must comply with the 
relevant EU directives for their devices. A set of harmonized standards exists to assists 
manufacturers with achieving compliance. Although it is not compulsory to follow these 
standards, vendors who do so will find easier to demonstrate compliance. 
Guidance and technical reports help medical device manufactures and regulatory 
authorities in assessing the classification of medical devices. They provide guidance in 
the application of standard practices during the medical device development process. 
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3.4.1 Standards applicable to medical device software 
There are a number of harmonized standards, each of them setting requirements for 
compliance in a given area (development process, risk management, quality 
management, etc.). These are the most relevant harmonized standards for medical 
device software development: 
 IEC 62304:2006, Medical Device Software - Software life cycle processes 
 ISO 14971:2007, Medical Devices - Application of risk management to medical 
devices 
 ISO 13485:2003, Quality management systems - Requirements for regulatory 
purposes 
 IEC 62366-1:2015 Medical Devices - Part 1: Application of usability engineering 
to medical devices 
The most relevant standard for the development of medical device software is IEC 
62304:2006. This standard defines the requirements for the software life cycle 
processes during the software development and maintenance phases. 
This standard defines a framework of life cycle processes for the safe development and 
maintenance of medical device software. The standard identifies processes, activities 
and tasks that have to be carried out during the development and maintenance phases 
in order to demonstrate compliance. Each life cycle process is divided in a set of 
activities and these are further decomposed into individual tasks. 
The standard assumes that medical device software is being developed and 
maintained within a quality management system and a risk management system. For 
risk management, the standard IEC 62304 requires the manufacture of medical device 
software to comply with ISO 14791. 
The standard requires that a software development plan must be documented and 
followed. However, the standard does not impose the use of any particular life cycle 
model. Manufactures of medical device software are free to choose and adapt any life 
cycle model that better suits their needs and current practices as long as the 
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processes, activities and tasks defined by the standard are being performed and 
documented within their life cycle. 
The standard identifies two additional processes considered essential for developing 
safe medical device software: software configuration management process and 
software problem resolution process. 
The figure below shows the software development process activities as described by 
the standard: 
 
Figure 3.1 - Overview of SW development processes and activities as defined in IEC 62304 
The standard considers the maintenance of the medical device software as important 
as its development. 
The figure below describes the software maintenance processes and activities: 
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Figure 3.2 - Overview of SW maintenance processes and activities as defined in IEC 62304 
A controlled and strict maintenance process needs to be in place in order to avoid 
incidents due to incorrect servicing or maintenance of the device, including software 
updates and upgrades. 
3.4.2 Guidance documents 
Various organizations including regulators, notified bodies and industry associations 
produce guidance documents to help manufacturers of medical devices with the 
interpretation of the regulations and the application of the standards. The technical 
information reports and guidance documents relevant for the development of medical 
device software include the following: 
 AAMI TIR45:2012, Guidance on the use of AGILE practices in the development 
of medical device software 
 MEDDEV 2.4/1 Rev.9 June 2010, Medical Devices - Classification of medical 
devices 
 MEDDEV 2.1/6 January 2012, Medical Devices - Qualification and 
Classification of standalone software 
 NB-MED/2.2/Rec4 Software and Medical Devices 
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 IEC/TR 80002-1:2009, Technical Report-Medical device software-part 1: 
Guidance on the application of ISO 14971 to medical device software 
 General Principles of Software Validation; Final Guidance for Industry and FDA 
Staff 
For the purpose of this thesis, the most relevant document is the technical information 
report AAMI TIR45:2012 produced by the Association for the Advancement of Medical 
Instrumentation. 
This technical information report provides recommendations for complying with 
international standards and with medical devices regulations when using Agile 
practices to develop medical device software. It also provides guidance to adapt Agile 
practices to fit the unique needs of medical device software development. 
This technical information report describes first the Agile perspective, explaining its 
goals, values, principles and practices. It then goes on to describe the goals, values, 
principles and practices that define the regulated world of medical device software 
development. Most of the Agile values and principles align very well with those of the 
regulatory perspective while others might provide some challenges. This document 
also provides medical device software manufacturers with recommendations on how to 
align the values and principles of both perspectives in a supportive manner. 
3.5 Summary 
Medical software development process is regulated by the competent authorities of the 
areas in which the software product will be marketed and taken into use. Standards 
and guidelines exist to assist development teams in the certification process. 
The standard IEC 62304:2006 provides a conceptual framework that covers the 
complete software development and maintenance phases. It identifies the processes, 
activities and tasks that are carried out when developing medical software; it describes 
the sequence and dependencies between activities and it identifies the milestones at 
which deliveries are verified. The standard requires that a software development plan 
exists and it is being followed. It does not mandate the usage of any concrete life cycle 
model, implying that development teams should adapt the one that best fits their needs 
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and the existing practices of their organizations (e.g., regarding the usage of quality 
and risk management systems). 
The table below summarizes the requirements set by the standard IEC 62304:2006 
grouped by categories: 
Table 3.1 - Software development process requirements as specified by IEC 62304:2006 
Quality management Demonstrated by compliance with ISO 13485 
Risk management Demonstrated by compliance with ISO 14971 
SW development process  Development and maintenance planning 
 Requirement analysis 
 Architectural design 
 Detailed design 
 Unit implementation and verification 
 Integration and integration testing 
 System testing 
 Releasing 
 Risk management process 
 Configuration management 
 Problem resolution 
 Change management 
The technical information report TIR45:2012 provides recommendations for complying 
with international standards (i.e., IEC 62304:2006) and with medical devices 
regulations when using Agile practices to develop medical device software. It also 
provides guidance to adapt Agile practices to fit the unique needs of medical device 
software development teams. 
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4 Guidelines for the Development of Medical Device SW 
4.1 Introduction 
As discussed in the previous chapter, the standard IEC 62304:2006 mandates that 
certain activities have to be performed and documented during the software 
development and maintenance phases. It does not mandate, however, in which 
sequence these activities should be performed. 
The standard IEC 62304, Section 5.1.1, requires that the medical device software 
manufacture choose and define their software development life cycle. Although the 
structure of the standard is heavily based on a Waterfall model, it does not impose the 
use of any particular life cycle model. 
In this chapter we will propose a number of guidelines for the development of medical 
device software following an Agile approach. We will provide guidelines for the 
software development process, the software maintenance process, the software risk 
management process, the software configuration management process and the 
problem resolution process. These guidelines are based on the Agile practices we 
introduced in Chapter 3 and the recommendations provided by the Association for the 
Advancement of Medical Instrumentation in their TIR45:2012. 
We will propose an evolutionary and iterative development life cycle. We will discuss 
how the development activities are defined in ways that the proposed processes 
comply with the requirements set by the medical devices regulations and relevant 
harmonized standards. 
The processes and activities proposed here are expected to be used by the case 
company software engineering team as guidance when developing and maintaining 
their medical device software. The Agile principle reflect and adapt must be observed 
in order to adapt the process at regular intervals to constantly improve the quality and 
efficiency of the work. 
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4.1.1 Vision based baby monitor 
The device being developed by the case company Circular Devices is a vision based 
baby monitor that detects the baby’s breathing movements and triggers an alarm if the 
movements stop. It is a stand-alone, dedicated device. Its hardware consists on an 
embedded microprocessor, a dual camera, infrared light emitting diodes used for 
illumination under dark operation conditions (night vision) and various input and output 
devices to control its operation and to produce acoustical and visual alarm signals. 
Software is a fundamental part of the medical device being developed. Software is 
responsible for detecting and monitoring the baby’s breathing movements using 
machine vision algorithms, measuring his respiratory frequency and producing an 
alarm if there's no breath for a set number of seconds, a condition known as apnoea. 
The diagram below shows a high level overview of the software architecture and the 
main components of the system: 
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Figure 4.1: SW architecture diagram 
At the bottom of the SW stack we find the Core OS layer which main components are 
the Linux kernel, the C library, camera drivers, audio drivers, graphics and display 
drivers and network stack. Most of these components are being developed by the open 
source community or by the respective device manufactures (e.g., camera drivers). 
The case company does not actively develop any of these components but it might 
submit to the upstream projects bug fixes or modifications made to them. For these 
components, the case company apply the SOUP maintenance plans and risk 
management process described later in this chapter. 
The next layer in the software stack is the Middleware layer. This layer is comprised of 
software libraries that provide certain specialized functionality, such as the OpenCV 
computer vision library, OpenGL graphic acceleration and various virtual machines and 
interpreters such as Java and Python. Most of these components are either open 
source or developed by their respective manufactures (e.g., Java is being developed 
by Oracle). The case company adds extra functionality at this layer by implementing its 
own machine vision algorithms. For the components being developed outside of the 
case company the SOUP processes apply. For those components being actively 
developed by the case company, the full development, maintenance and risk 
management processes described later in this chapter need to be followed. 
The top layer in the software stack is the Application layer. This layer is made of the 
high level applications that implement the full functionality of the device (e.g., the 
apnoea monitor). There are some other applications such as logging to keep track of 
any occurrences of apnoea as well as a messaging application that can be used to 
send alarms to other devices such as mobile phones or tablets. Any helper applications 
used for tracing and debugging during the development process belong to this layer as 
well. These applications are fully developed by the case company. The full 
development, maintenance and risk management processes apply to the components 
in this layer. 
4.1.2 Software safety classification of the baby monitor 
According to the Recommendation NB-MED/2.2/Rec4 Software and Medical Devices 
(Co-ordination of Notified Bodies Medical Devices 2001), depending on the intended 
use by the manufacturer, medical device software can be 
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a) a medical device or an accessory to a medical device, which must be CE-
Marked, or 
b) a component and integral part of a medical device, which cannot be CE marked 
in its own right, but which is covered by the conformity assessment of the 
medical device of which it forms a part or 
c) None of the above and therefore not covered by the Medical Devices Directives. 
In our case, the software being developed falls under the second category since it is a 
component and integral part of the baby monitor, which is a medical device. 
The case company intends to place the vision based baby monitor in the market as an 
infant or child apnoea monitor, which according to the Annex IX of the Council Directive 
93/42/EEC and MEDDEV 2. 4/1 Rev. 9 would be classified as a Class II medical 
device. 
The standard IEC 62304:2006 requires that the manufacturer assigns to each software 
system a software safety class (A, B or C) according to the possible effects on the 
patient, operator or other people resulting from a hazard to which the software system 
can contribute. 
 Class A: No injury or damage to health is possible 
 Class B: Non-serious injury is possible 
 Class C: Death or serious injury is possible 
The standard will require stricter risk management activities and higher levels of 
documentation for software systems with a higher safety class. 
4.2 Guidelines for the software development process 
A software development process defines the activities that are to be performed when 
developing a software product. The standard IEC 62304 requires manufacturers of 
medical device software to define and follow a development process when developing 
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their software products. In this section we will outline the proposed software 
development process based on Agile practices. 
4.2.1 Software development plan 
A software development plan must be created and updated regularly. This plan must 
include a reference to the software development life cycle model being used. The 
software development plan shall describe: 
 The processes used when developing the medical device software 
 The deliverables of each activity and task 
 Traceability between system requirements, software requirements, system tests 
and risk control measures implemented in software 
 Software configuration and change management 
 Software problem resolution process 
This plan must be kept up to date as the development proceeds. It must include 
references to system design and system development plans. The software 
development plan must include integration and testing plans. It shall cover as well 
software verification, risk management and documentation planning. Certain supporting 
items, such as development tools, chosen software settings, etc. which might impact 
the way the medical device software works shall be included in the development plan 
as well. 
In a sequential life cycle, such as waterfall or V-model, this planning will be naturally 
performed at the beginning of the process, before the software development begins. In 
an evolutionary life cycle model such as the one being proposed, planning activities are 
being performed at different layers of abstraction throughout the whole project lifetime, 
as we will discuss in the next sections. 
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4.2.2 Software development life cycle model 
The software development life cycle being proposed is based on an emergent and 
evolutionary model. It makes use of proven Agile techniques and practices and adapts 
them to the particular needs of a medical device software development context. 
Figure 5.1 provides a high level view of the proposed life cycle￼ (Schwaber and 
Beedle, 2002): 
 
Figure 4.1 - SW development life cycle model based on Scrum 
A “product backlog” consisting of “user stories” is created and its items are then 
arranged based on their priority. The “product owner” owns the backlog and he is 
responsible of updating and prioritizing it. At the beginning of each development 
iteration or “sprint”, the development team will go through the product backlog and will 
pick up the highest priority user stories to be worked on next. These stories will form 
the “sprint backlog”. The sprint backlog will be then further decomposed on tasks that 
developers can process during the sprint. These tasks include software design, 
implementation, integration, testing, verification, documentation, etc. Each day there is 
a “daily stand-up” meeting where the team members discuss their progress, identify 
any impediments and choose their next work tasks. At the end of the sprint, a “sprint 
review” is carried out where the team demonstrates the stories that have been 
completed during the sprint to the product owner and any other interested stakeholder 
(i.e., customer or marketing representative). The sprint review demonstrations are a 
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mechanism to gather continuous feedback from users. They serve as a tool for 
continuous requirements verification and validation by reducing the risk of incorrect 
requirements definition during the early phases of product development. The product 
owner accepts or reject these stories based on their completeness against the team’s 
“definition of done”. Accepted stories are marked as completed while rejected ones are 
taken back to the product backlog for re-prioritization. The team performs a “sprint 
retrospective” meeting where they learn about how the team worked during the sprint 
and those areas that require improvement are identified. 
Process flow 
The figure below describes the timeline of the development activities and the 
abstraction layers of the proposed software development process: 
 
Figure 4.2 - development process timeline 
The product development starts with the conception phase in which key product 
features are being identified. These features are then written in the form of user stories. 
User stories capture software features from an end-user perspective. The user story 
describes the type of user, what they want and why. A user story helps to create a 
simplified description of a requirement (Rouse, 2015). Following a preliminary analysis, 
these user stories are then prioritized in the product backlog. After that the first iteration 
or sprint can commence. In this first iteration the work consists mainly on a high level 
design of architecture and system core. A number of iterations are then performed until 
the system is deemed completed. These iterations consist of software architecture, 
detailed design, implementation, testing, integration, verification and documentation 
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activities and tasks. The output of these iterations are then grouped together to form a 
“release”, where further verification, validation, testing and integration is being 
performed. 
4.2.3 Software development activities 
The standard IEC 62304 defines a software development process model with a well-
established set of activities necessary to develop medical device software. The figure 
below illustrates how these activities are being performed when following an Agile life 
cycle such as the one being proposed: 
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Figure 4.3 - Mapping IEC 62304’s activities into Agile life cycle as defined by AAMI TIR45 
At the top of the figure are the activities defined by IEC 62304. The bottom part of the 
figure shows how those activities are executed in an incremental and evolutionary life 
cycle model. When following such development life cycle, these activities are 
performed several times at different levels of abstraction. 
In the proposed life cycle, we find four layers of abstraction: the project layer,  which 
consists of the whole set of activities needed to deliver a finished software product; The 
release layer consists of the activities needed to create a usable product, wherever 
meant to be used by the end user or for internal purposes only; The increment layer 
consists of the activities needed to create a set of useful functionality, although not 
necessarily a complete product; the story layer consists of the activities needed to 
create a small piece of functionality. The time span of these abstraction layers goes 
from the whole lifetime of the software product (project layer), three to six months for a 
release, two to four weeks for an increment and one to three days for one story. 
Next we will describe in more details how the software development activities defined 
by IEC 62304 are being performed at the different layers of abstraction in our 
development life cycle: 
Software development planning 
In the proposed development life cycle, software development planning is done at 
multiple layers. At the project layer, planning consists on the high-level activities of 
project management such as project scoping, forming the team, allocating resources 
and organizing the project into releases. At the release layer, planning addresses the 
mid-level activities of project management, such as scoping the release, scheduling the 
development activities within the release, defining integration points of the software and 
the rest of the system and organizing the release into increments. At the increment 
layer, planning addresses the low level activities of project management, such as 
scheduling and planning the low level activities, defining low level integrations points 
with other subsystems and organizing the increment into stories. At the story layer, 
planning addresses detailed team and individual planning, such as allocating tasks to 
individual team members, planning the execution of daily activities and tracking 
progress. 
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Feedback occurs within and between all layers of planning: during the daily stand-up 
meeting, developers share with the rest of the team what has been accomplished since 
the last daily meeting and bring up any issues that might be blocking their progress; 
during the sprint retrospective, the team reflect on how they are doing and find ways to 
improve. 
Software Requirements analysis 
Software requirements analysis occurs at two layers. At the project layer, software 
design inputs and specifications are processed and prioritized forming the initial 
product backlog which consists of high level definitions of the software 
requirements.  At the story layer, detailed specifications of the software are created. 
Software Architectural design 
Software architectural design is being done at two layers of abstraction. At the project 
layer, a high level architectural work happens (either by allocating a complete 
increment to establish the architectural infrastructure as illustrated in figure 5.2 or by 
defining smaller development tasks dedicated to architectural work not related to any 
specific story). At the story layer detailed architectural design emerges by following 
Agile principles such as simple design and refactoring. 
Software Detailed design, unit implementation and verification 
Software detail design and software unit implementation and verification occur at the 
story layer. Following the Agile concepts of simple design and refactoring, detailed 
designs emerges as code is being produced. By following a test-driven development 
methodology, unit tests are written and executed at the same time than the code is 
being developed. 
Software Integration and integration testing 
Software integration and integration testing occurs at three layers of abstraction. At the 
story layer, software is being integrated into the rest as the system as code is being 
developed by using a continuous integration system.  By following test-driven 
development methods, the integration is tested as the pieces are being put together. At 
the increment layer, test-driven development is used to integrate and test individual 
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stories as they are completed to create a complete set of related functionality. At the 
release layer, the integration of the complete sets of functionality provided by the 
different increments forming the release is then tested. 
Software System testing 
Software system testing occurs at three layers of abstraction. At the story layer, a test 
or other verification methods is created as the software requirement is defined. This 
test might be executed at the story layer or later at the increment or release layers 
when other required elements of the system are being integrated. At the increment 
layer, tests defined by the stories are executed or new ones are created to verify 
requirements related to subsystem integrations. At the release layer existing tests are 
executed once again or new ones are created to verify system level integration 
requirements. 
Software Release 
Software release activities are performed at the release layer. 
4.3 Guidelines for the software maintenance process 
The Standard IEC 62304 requires a software maintenance process to be established in 
addition to the software development process. The software maintenance process 
needs to be followed when performing software maintenance activities such as fixing 
defects, implementing change requests or when adding new software functionality 
(software upgrades) after the software product has been released to end users. 
This section describes the software maintenance process in the proposed Agile 
software development life cycle. 
4.3.1 Software maintenance plan 
A software maintenance plan has to be established for conducting the software 
maintenance activities described in section 4.4.1, figure 4.2. This maintenance plan 
should include the following: 
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 Procedures for receiving, documenting, evaluation, resolving and tracking 
feedback arising after the release of the medical device software 
 Criteria to determining whether the feedback is considered to be a problem 
 Use of the software risk management process 
 Use of the software problem resolution process 
 Use of the software configuration management process 
 Process to evaluate and implement upgrades, bug fixes, patches and 
obsolescence of SOUP 
4.3.2 Problem and modification analysis 
As part of the software maintenance process, any software defect or change request 
has to be analysed following a problem resolution process as described in section 5.6. 
4.3.3 Modification implementation 
After a software defect has been analysed and it has been found that it needs fixing or 
a change request has been approved for implementation, we shall follow the same 
Agile software development process as described in section 5.2. Software fixes or 
change requests items are added to the product backlog, with a clear marking (such as 
[BUG:XXX] or [CR:YYY] prefix in their title) to indicate that they originate from a defect 
report of change request. They are then prioritized together with the rest of items in the 
backlog. From here on the development activities don’t differ substantially whether they 
correspond to new functionality or defect fixing and change request (other than in the 
later cases the fix has to be sufficiently documented in the defect tracking or change 
management tools). 
4.4 Guidelines for the risk management process 
The standard ISO 14971 defines the application of risk management to medical 
devices. The case company develops medical device software that belongs to risk 
class A or B. 
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When developing medical device software, the manufacturer must identify the software 
items and potential causes that could contribute to a hazardous situation, including: 
 Incorrect or incomplete specification of functionality 
 Software defects in the identified software item functionality 
 Failure or unexpected result from SOUP 
 Hardware failures 
 Reasonably foreseeable misuse 
If a failure of SOUP used in the medical device software is a potential cause to a 
software item contributing to a hazardous situation, any publicly available anomaly list 
should be reviewed to identify any possible sequence of events that could lead to a 
hazardous situation. 
A risk management file must be maintained listing all potential causes of the software 
item contributing to hazardous situations. The sequence of events that lead to 
hazardous situations must be documented on this file as well. 
4.5 Guidelines for the software configuration management process 
The standard IEC 62304 requires a software configuration management process to be 
established when developing medical device software. Configuration items include 
developer tools, compilers, IDE, operating systems, testing tools, integration tools, 
Software of Unknown provenance (SOUP) and so forth. 
4.5.1 Identification of configuration items 
A mechanism to uniquely identify configuration items and their versions must be 
established. SOUP items are identified by a name, their manufacturer and a unique 
identifier such as version number or release date. 
A system configuration list must be created that lists all the configuration items and 
their respective versions for a given software product release. 
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4.5.2 Change control 
Configuration items must be changed only in response to an approved change request. 
The changes must be implemented as specified in the CR following the development or 
maintenance processes including appropriate verifications tasks. It is important to be 
able to trace any changes to configuration items. 
4.5.3 Configuration status accounting 
The history of changes to configuration items must be kept. It should be possible to 
retrieve the exact version of each configuration items for a given software product 
release. The consistent use of software version management and continuous 
integration tools can greatly simplify this task. 
4.6 Guidelines for the software problem resolution process 
A software defect tracking tool has to be configured and taken into used to track 
feedback originating both internally and from end users. The use of such tool serves as 
well as a mean to documenting the problem resolution analysis and fixing processes. 
By using unique identifiers (such as the bug or CR id’s), It also helps in tracking the 
sections of the source code being modified in order to address the defect or change 
request and to trace it during the rest of the development activities until it is finally 
made available to internal or end users as part of a software release. 
Each software problem report must include the following: 
 Type (example: corrective, preventive, or adaptive to new environment) 
 Scope (example: size of change, number of device models affected, supported 
accessories accepted, resources involved, time to change) 
 Critically (example: effect on performance, safety or security) 
The software maintenance process must be followed when implementing defects fixing 
activities as described in section 5.3.3 
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The figure below illustrates the software problem resolution process flow: 
 
Figure 4.4 - Problem resolution workflow 
Some of the key principles of Agile software development are improvement, reflexion, 
quality and safety. Hence an integral part of the problem resolution process consists on 
reviewing the problems trends, understand what the root causes behind these 
problems are and adapt the software development processes and practices in order to 
minimize defects and improve quality and safety. This reflexion occurs both at the 
story layer during the daily stand-up meetings and at the increment layer during the 
team’s retrospective meeting. 
Regulators, end users of the software product and any other affected parties must be 
informed of the existence of the problem. Once a corrected version of the software has 
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been released it must be made available to existing users with instructions on how to 
apply the upgrade. 
4.7 Summary of the guidelines for the creation of medical device software 
Creating medical device software consists not only on developing the software as such 
but also the maintenance of the software during the product life cycle, configuration 
management, risk management and problem resolution process once the product has 
been placed into the market. In order to comply with the EU directives regulating the 
development and manufacturing of medical devices and being granted certification for 
the final product, certain activities have to be performed and documented during all 
these phases of the medical device software creation. 
The mind map below summarizes the guidelines being proposed: 
 
Figure 4.5 - Guidelines for the medical device software creation 
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In this chapter we have outlined a set of guidelines that the case company should 
follow when creating medical device software to ensure compliancy with the existing 
medical device regulations. These guidelines are based on Agile practices that 
enhance the safety, quality and performance of the software being created. These 
guidelines have been presented grouped according to the phase of the software life 
cycle that they apply. The software development activities that have to be performed to 
comply with the standard IEC 62304:2006 have been mapped to the relevant 
development phases in an evolutionary and iterative life cycle such as the one being 
proposed here. 
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5 Conclusions 
This chapter summarizes the work done in this thesis. We will describe the limitations 
of this thesis and outline the next steps the case company would need to complete 
before it can place into the market the medical device under development. We will 
conclude with an evaluation of this thesis by comparing it outcome against the 
objective described in Chapter 2. We will as well discuss about the reliability and 
validity of this thesis. 
5.1 Summary of the thesis 
The case company, Circular Devices Oy, is developing a vision based infant apnoea 
monitor that is intended to be used for the prevention of the Sudden Infant Death 
Syndrome (SIDS). As discussed in Chapter 4, any device which primary function is, as 
defined by its manufacturer, to prevent, diagnose or treat a medical condition is 
considered as a medical device. Therefore, it must comply with the relevant medical 
device regulations before it can be sold (MEDDEV   2. 4/1 Rev. 9 2010). These 
regulations apply to all the components of the medical device, including its software. In 
Europe, Directive 93/42/EEC defines the rules that regulated the safety and 
performance of medical devices. Directive 2007/47 EC introduced the last technical 
revisions to Directive 93/42/EEC. 
International organizations such as the International Standardization Organization 
(ISO) and the International Electrotechnical Commission (IEC) have published a 
number of harmonized standards to help manufacturers of medical devices to comply 
with the international regulations. The standard IEC 62304:2006 Medical device 
software -- Software life cycle processes defines the requirements for the software life 
cycle processes during the software development and maintenance phases. The 
standard identifies processes, activities and tasks that have to be carried out during the 
development and maintenance phases in order to demonstrate compliance. 
Although the standard IEC 62304:2006 does not impose the use of a particular life 
cycle, its layout and organization is heavily influenced by a waterfall, sequential 
software development life cycle. The Association for the Advancement of Medical 
Instrumentation (AAMI) have published a document titled Guidance on the use of Agile 
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practices in the development of medical device software to address the challenges and 
particularities faced by manufacturers of medical device software when following Agile 
methods in the medical device environment. 
The case company needs to define its own software development practices in a way 
that they comply with the European directives regulating the development of medical 
devices by following the international standards mentioned above. This is the business 
problem that this thesis sought to solve. 
In this work we followed the research steps described in Chapter 2: 
First we reviewed a number of case studies that discuss the benefits and challenges 
faced by established medical device manufacturers when introducing Agile 
methodologies into their software development teams. One interesting observation was 
that most of the challenges the authors described had to do with the changes Agile 
introduced into their current ways of working and corporate cultures rather than having 
difficulties demonstrating compliance to the standards during audits. The benefits of 
Agile methods in terms of software quality, productivity and team motivation were 
apparent. We outlined the Agile values, principles and practices in the context of 
medical device software. 
After that, we analysed in depth the medical device software standards and industry 
guidelines on the use of Agile. We then carried out semi-structured interviews with 
industry experts to get insights on how their organizations have introduced Agile 
methodologies for the development of medical device software. 
We concluded this work by proposing an evolutive and iterative software development 
life cycle and proposing a set of Agile software development practices that the case 
company can use as guidance when developing the medical software for its infant 
apnoea monitor. 
5.2 Limitations and future research 
This thesis presents a number of limitations and opportunities for future research. First 
of all, there are geographical limitations: this thesis focuses on the requirements set by 
regulators for the commercialization of medical devices in Europe. However, the 
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international standards and industry guidelines used in this theses (such as IEC 
62304:2006 and AAMI TIR45:2012) are widely recognized by regulators elsewhere in 
the world (i.e., FDA in the United States). As a future research, we should study the 
regulations for medical devices in the other geographical areas where they case 
company intent to sell the device. We should ensure that our software development 
practices fulfil those requirements and adapt them when necessary. 
There are also limitations in scope: this thesis focuses on the software part of a new 
medical device, concretely on the software development process used when 
developing medical device software. In order to obtain certification for the new medical 
device, the complete device has to fulfil the quality and safety requirements set by 
regulators for medical devices. Quality and risk management processes need to be 
defined and follow during the development of all parts of the medical device. A future 
research would include the development of a set of work instructions for the 
development and assembly of the hardware components of this medical device. 
Focusing on the software development process being proposed in this thesis, the 
natural next steps would be to perform a number of development iterations or sprints to 
validate and improve it. As we discussed in Chapter 5, the Agile principle reflect and 
adapt must be observed in order to adapt the process at regular intervals to constantly 
improve the quality and efficiency of the work. 
5.3 Evaluation of the thesis 
5.3.1 Objective vs outcome 
The objective of this thesis was to propose a set of software development guidelines 
based on Agile practices that the case company can follow when developing medical 
device software in order to comply with the EU Medical Device Directives. After 
analysing in depth the medical device regulations, the relevant harmonized standards 
and industry guidelines alongside with the insights gained from semi-structured 
interviews with industry experts, we proposed a number of Agile software development 
practices for each of the phases of the software creation process addressed by said 
standards (i.e., software development plan, life cycle model, software development 
activities, software maintenance process, risk management, software configuration and 
problem resolution). 
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As mentioned earlier when discussing the limitations of this thesis, it would have been 
beneficial to perform a number of iterations to better refine and adapt the practices 
being proposed here to the actual environment and needs of the case company. 
5.3.2 Reliability and validity 
In order to ensure the trustworthiness of this research, we will apply the model 
proposed by Guba (1981). In this model, the author of qualitative inquiries must 
consider the following four criteria when conducting their studies: credibility, 
transferability, dependability and confirmability (Shenton, 2004). 
Credibility 
In a qualitative study, credibility means that the findings of the study are congruent with 
reality. Credibility is one of the most important factors in establishing trustworthiness 
(Lincoln and Guba, 1985). 
In this thesis credibility is being achieved by utilizing well defined research methods 
such as semi-structured interviews, performing literature reviews of the relevant 
documents, such as regulations, standards, industry guidelines and published case 
studies and following clear research steps as described in depth in Chapter 2. 
Transferability 
Transferability is concerned with the extent to which findings of one study can be 
applied to other situations (Merriam, 1998). 
In this study transferability is achieved by reviewing a sufficient number of cases 
studies where Agile software methodologies are being used in medical device 
organizations; by utilizing principles, values and practices commonly used and 
acknowledged by the Agile community and by performing interviews with industry 
experts with different roles from organizations where Agile has been taken into use 
when developing medical device software. 
Dependability 
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Dependability is the equivalent to reliability in a quantitative study. Reliability is based 
on the assumption of replicability or repeatability. Since in a qualitative study it is 
impossible to measure the same thing twice, dependability is used to ensure that the 
study could be repeated although not necessarily to obtain the same results. 
In this study, dependability is being ensured by defining a clear research design 
process and research steps as it has been discussed in Chapter 2.  
Confirmability 
Confirmability refers to the degree to which the results could be confirmed or 
corroborated by others. 
In this study confirmability is being achieved on one hand, by describing the way the 
research process has been performed in as much detail as possible. On the other 
hand, confirmability is achieved by acknowledging the limitations of the research as it 
was discussed in details earlier in this chapter. 
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Industry experts interviews 
Interviewee #1 
Company: GE Healthcare  
Title: Lead Software Engineer 
Position: Epic Owner / Team Lead 
Total work experience: 15 years 
Date: 1 August 2015 
Below is a summary of the interview organized by the SW development topics that 
were discussed during the theme interview. 
SW life cycle and SW development methodologies 
GE Healthcare uses an iterative SW life cycle. However, some activities such as final 
validation and verification, design transfer to manufacturing and clinical pilots in 
hospitals are being performed sequentially after the other R&D activities have been 
completed. 
GE follows Agile practices. There are some challenges when following Agile though. 
For example, it is nearly impossible to do content pruning or to drop features of a 
medical device (i.e., you just can’t sell a patient monitor lacking ECG functionality). 
Also schedules are really tight in the medical device industry because of the way the 
purchases process typically works in hospitals: budget allocation for new equipment 
might be done even before the device has been developed. Once the purchase is 
done, the devices must be supplied on the agreed time and it must contain all the 
features. Delays on the delivery of the device caused by SW must be avoided. 
SW validation and verification (V&V) 
SW verification at GE Healthcare tests that the device works as specified. The SW 
verification is being done incrementally as the SW is being developed. GE follows a 
test driven development (TDD) process. Integration testing is being done incrementally 
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within the sprint and as part of the release activities. All tests results at all development 
layers are logged and documented for future reference during certification or audits. 
SW validation checks that the SW meets it intended use. SW validation is carried out in 
increments during the development process of the device by clinicians at hospital. They 
use prototype devices as secondary devices so that they can evaluate how they 
perform compared to the current equipment. 
At the very end of the development process and before “design transfer to 
manufacturing”, a final round of thorough verification and validation (V&V) is then 
carried out. For this phase some of the same tests produced during the development 
are re executed as well as new ones to minimize the chances of defects being found 
after manufacturing has started. 
Safety classification 
Each of the features or functions of the device receive a safety classification based on 
the level of control needed to ensure safety and effectiveness of the device. 
The highest classification of each of the functions that the device implements will 
determine the classification of the device itself. 
Risk and change management 
During the SW R&D, the team must identify and list all the possible SW hazards that 
might cause harm to the patient. Each hazard is assigned a probability (likelihood that 
the hazard occurs), a visibility (if the hazard occurs, will it be visible to the clinicians?) 
and the harm it can cause (e.g., skin burn). A risk classification is then done using 
these three parameters as inputs. 
The mitigation of the risk will depend on its classification. For some, it will be enough to 
implement some additional safety features by software. Other will require mitigation by 
hardware. In any case, risk has to be mitigated as far as it is feasible and reasonable. 
In the case that there is no way a risk could be completely mitigated, a warning must 
be placed on the user manual of the device. 
Roles and team organization 
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GE Healthcare follows an Agile approach when it comes to team organization and roles 
definition. It uses roles and artifact somehow similar to those found in Scrum but using 
its own terminology: a “Lead System Designer” (Product Owner in Scrum) is 
responsible for the content and prioritization of the product backlog. He is the contact 
between the team and marketing and sales organizations as well as clinicians working 
on the development of the device. An “Epic Owner” is responsible for the end to end 
functionality and performance of a certain application of function performed by the 
device (i.e., The Epic Owner for ECG measurement in a patient monitor device is 
responsible for everything related to ECG “skin to screen”, meaning from sensors that 
are attached to the patient and acquisition modules all the way up to data visualization 
on the device’s screen). The team is self-organized with work being divided in “sprints” 
(usually three weeks). The content of the sprint is agreed between the team and the 
Lead System Designer during the sprint planning meeting. Within the sprint, the team 
has daily scrum meetings. The scrum master helps the team on the daily work activities 
and help solving any obstacles the team might encounter while doing their work. 
Interviewee #2 
Company: GE Healthcare 
Title: Research Engineer 
Total work experience: 20 years 
Date: 15 August 2015 
This interview was focused on the Agile Software Development Life Cycle (SDLC) used 
at GE Healthcare. 
GE Healthcare has developed its own Agile SDLC based on various regulations and 
international standards: MDD 93/42/EEC, 21 CFR Part 820, IEC 62304:2006 and 
FDA’s General Principles of Software Validation (GPSV). 
The purpose of the SDLC is to protect patient and users of medical devices and 
maintain public safety by ensuring that the software is safe, effective and that risks are 
at an acceptable level. 
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The SDLC developed by GE Healthcare support many SW development 
methodologies. A dedicated “Work instruction” exists that provide guidance to the use 
of Agile SDLC.   
The SDLC must address the requirements for risk management of medical devices. 
GE Healthcare performs formal design reviews (FDR) at regular intervals to ensure that 
the SW being developed fulfils the requirements set by regulators for medical device 
software. There are three FDR during the SW development process, each focusing on 
different aspects of the process. During these formal reviews, the development team 
and other stakeholders (including management) evaluate aspects such as the software 
architectural design, software requirements, software design, unit implementation and 
unit testing, software verification, etc. During the last FDR, the SW release and SW 
maintenance are evaluated as well as the final design validation. 
In an iterative and evolutionary life cycle such as Agile, these design reviews are being 
performed accordingly in an iterative manner and at different depths during the SW 
development process. 
 
 
 
 
